Screener
Vor Biopharma VOR Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
| (in thousands, except share and per share amounts) | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ deficit(1): | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 0 shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 800,000,000 and 400,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; 54,185,582 and 38,720,196 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 19 | 18 |
| Additional paid-in capital | 1,222,823 | 988,604 |
| Accumulated other comprehensive (loss) income | (706) | 41 |
| Accumulated deficit | (1,372,560) | (1,152,975) |
| Total stockholders’ deficit | (150,424) | (164,312) |
| Total liabilities and stockholders’ deficit | $506,746 | $464,126 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Vor Biopharma's retained earnings?
- Vor Biopharma (VOR) reported retained earnings of -$1.37B in Q1 2026.
- How has Vor Biopharma's retained earnings changed year-over-year?
- Vor Biopharma's retained earnings decreased by 180.4% year-over-year, from -$489.48M to -$1.37B.
- What is the long-term trend for Vor Biopharma's retained earnings?
- Over 5 years (2020 to 2025), Vor Biopharma's retained earnings has grown at a 79.9% compound annual growth rate (CAGR), from -$61.22M to -$1.15B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Vor Biopharma's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude